nanosynth Group confident about the near term prospects of the business

nanosynth group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has presented its unaudited half yearly report for the six-month period ended 30 June 2022.

Operational highlights for the period:

·      Successful trial results with Volz Holdings and REACH UK registration

o  Creating potential to lead to wider adoption by the global filtration industry

o  Pipeline of interest is already at an advanced stage

·      Joint development agreement with a global wellness company for their first project in the cosmetics market

o  On successful completion, opportunity to enter into an exclusive commercial agreement for the supply of nanoparticles for this cosmetics market

·      New share subscription agreement to raise £2,942,500

o  Proceeds to be used primarily to fund its working capital requirements as the Group looks to commercialise its bespoke nanoparticle technology

·      Directors continue to purchase shares in the Company

o  Confidence in considerable potential of the Group’s nanoparticle technology

·      Strengthened Board

o  New board members enhance commercial expertise and corporate governance

Mark Duffin, nanosynth Chief Executive Officer commented:

“We are pleased with the recent updates that we have been able to share as a result of the hard work especially during the last 12 months.  The REACH UK registration will allow our partner Volz to apply antiviral technology to all their products.  This has the potential to lead to wider adoption by the global filtration industry.  The first project in our R&D programme that was secured is a testimony to our leadership in the nanotechnology market.  Confidentiality and competitive advantage remain our priority during the development stage and we look forward to potentially becoming exclusive partners in the future. The funding arrangements with Lanstead provide further working capital as the Group looks to commercialise its bespoke nanoparticle technology.

“As a result, we are very excited about the future of the business and are confident about the near term prospects of the business.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Share on twitter
    Share on linkedin
    Nanosynth Group plc

    More articles like this

    Nanosynth Group

    nanosynth group to raise £0.4 million via Placing and Subscription

    nanosynth group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced a conditional placing to raise gross proceeds of £0.4 million through the issue of 222,222,222

    Nanosynth Group plc

    Nanotechnology in cosmetics and cosmeceuticals

    Nanoparticles (NPs) are defined as materials with dimensions smaller than 100 nm and presenting various shapes, i.e., spheres, rods, dendritic shapes, etc. This definition is accepted by the European Union (EU) Commission. It should be noted, however, that there

    Nanosynth Group plc

    Nanoparticles in cosmetics

    Nanoparticles are particles that are smaller than 100 nanometer (1/10,000 millimeter) which is about 40,000 times thinner than a hair. There are two forms of nanoparticles: soluble and biodegradable nanoemulsions such as liposomes and insoluble nanopigments such as

    Nanosynth Group plc

    What nanoparticles do to our cells

    During the past few years, nanoparticles have been increasingly present in our everyday lives. To gain a better understanding of their health impacts, several studies have focused on the effects they have on our bodies and cells. “Because

    Nanosynth Group plc

    The therapeutic potential of nanotechnology beyond COVID-19

    It’s been years in the making, but the promise of messenger (m)RNA vaccines has finally been realized, thanks to a global pandemic that accelerated research and innovation in the field. But the success of mRNA vaccines would not have

    Nanosynth Group plc

    Role of nanotechnology for design and development of cosmeceutical

    Nanotechnology is an innovative area of science that includes the design, characterization, production, and application of materials, devices and systems by controlling shape and size at the nanometer scale (1–100 nm). Nanotechnology incorporation in cosmetic formulation is considered

    Nanosynth Group plc

    Nanotech could be the next frontier of drug delivery

    Nanotechnology is an emerging and rapidly developing area in the pharmaceutical and medicinal field. For example, nanoparticles can be used as drug delivery systems. Nanotechnology could help overcome the limitations of conventional drug delivery such as biodistribution and intracellular trafficking.

    Nanosynth Group plc

    Nanoparticles to aid cancer treatments

    Conventional therapies in cancer treatment face challenges in delivery of drugs in the body and just the quantity needed, due to the toxic nature of the medicines used that have unwanted side effects. Nanomaterials have ‘enormous’ potential in

    Nanosynth Group plc

    Nanoparticles: Emerging trends in human health and environment

    As part of the ongoing Govt of India initiative “Azadi ka Amrit Mahatosav”, the Indian Journal of Biochemistry and Biophysics (IJBB), CSIR-National Institute of Science Communication and Policy Research (NIScPR), New Delhi, has brought out its November 2022

    Nanosynth Group plc

    Nanoparticles that self-assemble inside cells to fight cancer

    Inspired by viral replication, researchers developed a therapy that commandeers biological processes to craft nanoparticles within macrophages to aid in cancer therapy. Through self-assembly, the nanoparticles address some of the delivery issues plaguing present renditions of nanomedicines, wherein nanomaterials

    Nanosynth Group plc

    nanosynth Group getting a huge amount of traction (LON:NNN)

    nanosynth’s Mark Duffin discusses what the company does, the Volz trial results, joint venture with a global wellness company and what investors can expect for the rest of the year in this exclusive interview with DirectorsTalk.

    Nanosynth Group plc

    Nanotechnology in the nutricosmetics industry

    Nanotechnology for Nutricosmetics Nanocarriers are ubiquitous within nanomedicine; however, with skin quality and health in high demand for consumers, these fields have overlapped. The use of nanotechnology and nanoformulations as delivery systems for improving the performance of active

    Nanosynth Group plc

    Nanotechnology in cosmetics

    Nanotechnology is the science of manipulating atoms and molecules in the nanoscale – 80,000 times smaller than the width of a human hair. The world market for products that contain nanomaterials is expected to reach $2.6 trillion by

    No more posts to show